Gabriel Chodick

15.1k total citations · 5 hit papers
378 papers, 8.2k citations indexed

About

Gabriel Chodick is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gabriel Chodick has authored 378 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 63 papers in Surgery and 50 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gabriel Chodick's work include SARS-CoV-2 and COVID-19 Research (23 papers), Diabetes Treatment and Management (21 papers) and COVID-19 Clinical Research Studies (19 papers). Gabriel Chodick is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Diabetes Treatment and Management (21 papers) and COVID-19 Clinical Research Studies (19 papers). Gabriel Chodick collaborates with scholars based in Israel, United States and United Kingdom. Gabriel Chodick's co-authors include Varda Shalev, Anthony Heymann, Ehud Kokia, Inbal Goldshtein, Sivan Gazit, Amir Ben‐Tov, Tal Patalon, Rachel Katz, Idan Yelin and Roy Kishony and has published in prestigious journals such as Science, JAMA and Journal of Clinical Investigation.

In The Last Decade

Gabriel Chodick

358 papers receiving 8.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

2021 305 citations Esma Herzel, Amir Ben‐Tov et al. profile →
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

2019 223 citations Gabriel Chodick et al. profile →
Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections

2022 205 citations Esma Herzel, Gabriel Chodick et al. profile →
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women

2021 191 citations Inbal Goldshtein, Ran S. Rotem et al. profile →
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

2023 68 citations Ran S. Rotem, Gabriel Chodick et al. profile →

Peers

Countries citing papers authored by Gabriel Chodick

Since Specialization

Citations

This map shows the geographic impact of Gabriel Chodick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Chodick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Chodick more than expected).

Fields of papers citing papers by Gabriel Chodick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Chodick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Chodick. The network helps show where Gabriel Chodick may publish in the future.

Co-authorship network of co-authors of Gabriel Chodick

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Chodick. A scholar is included among the top collaborators of Gabriel Chodick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Chodick. Gabriel Chodick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center 2025 ·Frontiers in Pharmacology ·(unknown), Miriam Davidovits, Gabriel Chodick, (unknown), Orit Peled	1
2	Inflammatory bowel disease is associated with an increased risk of cardiovascular events in a sex and age-dependent manner: A historical cohort study 2025 ·International Journal of Cardiology Cardiovascular Risk and Prevention ·(unknown), Gabriel Chodick	1
3	An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes 2025 ·The Journal of Clinical Endocrinology & Metabolism ·Tal Schiller, (unknown), Oren Barak, (unknown), (unknown), Gabriel Chodick, Edi Vaisbuch, Yael Barer	1
4	A machine learning tool for early identification of celiac disease autoimmunity 2024 ·Scientific Reports ·Michael Dreyfuss, (unknown), Benjamin Lebwohl, (unknown), (unknown), (unknown), (unknown), (unknown), Sivan Gazit, Tal Patalon, Gabriel Chodick, Yehuda Shoenfeld, Amir Ben‐Tov	1
5	Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir–Ritonavir: Real-World Data Analysis 2024 ·Journal of Clinical Medicine ·Clara Weil, Lilac Tene, Gabriel Chodick, Noga Fallach, Wajeeha Ansari, (unknown), ‪Yasmin Maor‬‏	0
6	Real-World Drug Survival of Biologics and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs Among Patients with Psoriatic Arthritis 2024 ·Drugs & Aging ·(unknown), Howard Amital, Gabriel Chodick, (unknown), Omer Gendelman	2
7	Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era 2024 ·Frontiers in Oncology ·(unknown), (unknown), Ashwini Arunachalam, Sivan Gazit, Moshe Hoshen, Gabriel Chodick, Nava Siegelmann‐Danieli	0
8	Adherence with statins and all‐cause mortality in days with high temperature 2024 ·Pharmacoepidemiology and Drug Safety ·Gabriel Chodick, Ran S. Rotem, Todd A. Miano, Warren B. Bilker, Sean Hennessy	1
9	Epidemiology and Healthcare Service Utilization among Adults with Chronic Cough 2024 ·Journal of Clinical Medicine ·Gabriel Chodick, Yael Barer, (unknown), (unknown), (unknown), (unknown), Neville Berkman	2
10	Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1 inhibitors 2023 ·Seminars in Arthritis and Rheumatism ·Yoel Levinsky, (unknown), (unknown), Gabriel Chodick, (unknown), Liora Harel, Gil Amarilyo	2
11	Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel 2023 ·Journal of Neurology ·Yael Barer, (unknown), (unknown), Xiaolan Ye, Jorge Zamudio, Tanya Gurevich, Gabriel Chodick	1
12	Evaluation of sputum cultures in children with spinal Muscular atrophy 2023 ·Respiratory Medicine ·(unknown), Yoram Nevo, (unknown), Huda Mussaffi, Gabriel Chodick, Meir Mei‐Zahav, Patrick Stafler, Guy Steuer, O. Baron, (unknown), Dario Prais, Sharon Aharoni	3
13	Impact of the COVID-19 Pandemic on Clinical Findings in Medical Imaging Exams in a Nationwide Israeli Health Organization: Observational Study 2023 ·JMIR Formative Research ·Michal Ozery-Flato, (unknown), (unknown), (unknown), (unknown), Gabriel Chodick, Michal Rosen‐Zvi, Michal Guindy	1
14	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study 2022 ·Clinical Infectious Diseases ·Sivan Gazit, (unknown), Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben‐Tov, Esma Herzel, Hillel Alapi, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon	90
15	The contribution of the Neurobehavioral Screening Tool to identifying fetal alcohol spectrum disorders in children at high risk of prenatal alcohol exposure and neurobehavioral deficits 2022 ·Early Human Development ·(unknown), Yehuda Senecky, Gabriel Chodick, Esther Ganelin‐Cohen	4
16	Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study 2021 ·International Journal of Women s Health ·(unknown), Avital Bareket‐Samish, Gabriel Chodick, Nava Siegelmann‐Danieli	4
17	Proton pump inhibitors long term use‐trends and patterns over 15 years of a large health maintenance organization 2021 ·Pharmacoepidemiology and Drug Safety ·(unknown), (unknown), Gabriel Chodick, Revital Kariv	4
18	Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome – Is It Related to Ethnicity? An Israeli Multicenter Cohort Study 2020 ·The Journal of Pediatrics ·Gil Amarilyo, Liora Harel, (unknown), (unknown), Riva Brik, (unknown), Ronen Bar‐Yoseph, Meir Mei‐Zahav, (unknown), Yoel Levinsky, Gabriel Chodick, (unknown)	14
19	Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy 2016 ·Annals of Pharmacotherapy ·(unknown), Jingbo Yu, Inbal Goldshtein, Sofia Ish‐Shalom, Vanessa Rouach, Varda Shalev, Ankita Modi, Gabriel Chodick	17
20	Prevalence and Factors Associated With Resistant Hypertension in a Large Health Maintenance Organization in Israel 2014 ·Hypertension ·Dahlia Weitzman, Gabriel Chodick, Varda Shalev, Chagai Grossman, Ehud Grossman	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact